Review

PD-1, PD-L1 mechanism and cancer treatment

Aslı Babayakalı, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.019
2348 2232

Neurotransmitters and hair loss

Aylin Kayaaltı, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.020
4109 12872

RIPK1 and obesity-induced inflammation

Aslı Melike Ekmekçi, Fehmi Balandi, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.021
2642 1986

Terazosin and neuroprotection

Ayşe Yürekli, Atakan Ölçenoğlu, Manolya Yıldız, Begüm Arda, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.022
4549 2350

Tumor markers and clinical use

Burak Akverdi, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.023
5927 6961

Alkaliptosis: A new strategy for cancer therapy

Beyza Emine Kılınç, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.024
3660 2717

Subgenual anterior cingulate cortex and psychiatric disorders

Berfin Sıla Akdoğdu, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.025
5085 1965

Bone marrow transplantation use on treatment solid tumors

İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.026
2587 2170

Superparamagnetic iron oxide nanoparticles use in the temporal lobe epilepsy model

Özge Çağlar, Elif Özyılmaz, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.027
2416 1985

Effect of mitochondrial dysfunction and oxidative stress on the pathogenesis of autism spectrum disorders

Umut Yücel, İrem Kahramanoğlu, İlknur Altuntaş, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.028
5532 2508

Cancer cells and alpha-ketoglutarate

Yalda Sadeghian, İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.029
3687 2872